Industry News
- Cassiopea announces FDA acceptance of its new drug application for clascoterone cream 1%, the first new mechanism of action for acne in nearly 40 years.
New Medical Research
- Acne fulminans and cutibacterium acnes phylotypes.
- Evaluation of the safety and efficacy of a picosecond alexandrite laser with DLA for acne scars in Chinese patients.
- Treatment of erythematotelangiectatic rosacea with pulsed-dye laser and oxymetazoline 1.0% cream: A retrospective study.
- Impact of nanostructured lipid carriers on dapsone delivery to the skin; In vitro and in vivo studies.
- Use of a monofilament debridement pad in the treatment of acne vulgaris.
- Establishment of an anti-acne vulgaris evaluation method based on TLR2 and TLR4-mediated interleukin-8 production.
- Prevalence and psychological impact of acne vulgaris in female undergraduate medical students of Rawalpindi and Islamabad, Pakistan.
Clinical Reviews
- Serum IL-36α, IL-36β, and IL-36γ levels in patients with hidradenitis suppurativa: Association with disease characteristics, smoking, obesity, and metabolic syndrome.
- Acne from the young patient's perspective.
- Trifarotene: First approval.
- The skin and gut microbiome and its role in common dermatologic conditions.
- Acne vulgaris: A patient and physician's experience.
- Young people's perceptions of acne and acne treatments: Secondary analysis of qualitative interview data.
- Demographic and clinical features of hidradenitis suppurativa in Turkey.
- Prevalence and impact of dietary avoidance among individuals with hidradenitis suppurativa.
- Blue-light therapy for acne vulgaris: A systematic review and meta-analysis.
- Skin changes in the obese patient.
- Incorporation of benzoyl peroxide nanocrystals into adapalene-loaded solid lipid microparticles: Part II - solid-in-oil dispersion of nanoparticulate benzoyl peroxide.
- Sarecycline hydrochloride for the treatment of acne vulgaris.
- Treatment of Demodex-associated inflammatory skin conditions: A systematic review.
- Association of rosacea with inflammatory bowel disease: A MOOSE-compliant meta-analysis.
- Skin disease related to metabolic syndrome in women.